WHO recommends dolutegravir as preferred HIV treatment (Mexico Update, IAS 2019) 22 July 2019 News release Mexico City Based on new evidence assessing benefits and risks, the WHO recommends the …
Public Health Initiative, A Registered Non-profit organization – All Right Reserved. 2011-2024. Contact us.